# VASOPRESSIN
> **ANDA217987** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2023-12-06
## Drug
- **FDA Application Number:** ANDA217987
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** VASOPRESSIN
- **Generic name:** Vasopressin
- **Active ingredients:** VASOPRESSIN
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** CIPLA
- **First approval:** 2023-12-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217987)
---
*AI Analytics · CC0 1.0*